KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Selecta Biosciences Inc Stock and on which exchange is it traded?
The symbol for Selecta Biosciences Inc is SELB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Selecta Biosciences Inc Stock?
Selecta Biosciences Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Selecta Biosciences Inc Stock?
Selecta Biosciences Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Selecta Biosciences Inc Stock.

What's the current price of Selecta Biosciences Inc Stock?
As of the end of day on the Feb 12, 2024, the price of an Selecta Biosciences Inc (SELB) share was $0.88.

What is the 52-week high and low for Selecta Biosciences Inc Stock?
The 52-week high for Selecta Biosciences Inc Stock is $1.99 and the 52-week low is $0.81.

What is the market capitalization of Selecta Biosciences Inc Stock?
As of the Feb 12, 2024, the market capitalization of Selecta Biosciences Inc is 135.201M.

When is the next earnings date for Selecta Biosciences Inc?
The upcoming earnings date for Selecta Biosciences Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About Selecta Biosciences Inc

Selecta Biosciences Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the t... SELB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT